Gutierrez, C.L.D. (2026) “High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax”, Journal of Medical Cases, 17(4), pp. 146–152. doi:10.14740/jmc5237.